Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy

ανά Marachelian, Araz, Desai, Ami, Balis, Frank, Katzenstein, Howard, Qayed, Muna, Armstrong, Michael, Neville, Kathleen A., Cohn, Susan L., Bush, Mark, Gunawan, Rudy, Lim, Allison Pecha, Smith, Malcolm A., Mary Smith, L.
Τόπος έκδοσης Cancer Chemother Pharmacol (2016)